Atherosclerosis and Cardiovascular Disease: 7th International Meeting
Editat de G.C. Descovichen Limba Engleză Paperback – 10 noi 2011
Preț: 393.95 lei
Preț vechi: 414.69 lei
-5% Nou
Puncte Express: 591
Preț estimativ în valută:
75.39€ • 78.42$ • 62.24£
75.39€ • 78.42$ • 62.24£
Carte tipărită la comandă
Livrare economică 14-28 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789401068147
ISBN-10: 9401068143
Pagini: 760
Ilustrații: 756 p.
Dimensiuni: 155 x 235 x 40 mm
Greutate: 1.04 kg
Ediția:Softcover reprint of the original 1st ed. 1990
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9401068143
Pagini: 760
Ilustrații: 756 p.
Dimensiuni: 155 x 235 x 40 mm
Greutate: 1.04 kg
Ediția:Softcover reprint of the original 1st ed. 1990
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
1 Cholesterol-CHD connection: evidence for the benefit of lipoprotein modification.- Epidemiological Studies on Atherosclerosis and Coronary Heart Disease.- Genetics of Coronary Heart Disease and Atherosclerosis: Clinical and Epidemiological Implications.- The Vegetative Nervous System and Cardiovascular Disease.- Nosology of Hyperlipoproteinemias.- Nutrition: Population Studies.- Nutrition: Special Diets and Metabolic Effects of Fats and Proteins.- Athersclerosis, Computer Handling Studies and Mathematical Modelling.- New Perspectives in the Treatment of Hypercholesterolemia and the Prevention of Atherosclerosis.- LDL Apheresis: Efficacy Versus Ethical and Social Aspects.- Developments in Lipoprotein and Apoprotein Research.- Thrombosis and Atherosclerosis: Clinical Insights.- Glycosaminoglycans and their Clinical Implications.- Calcium Antagonists and Atherosclerosis.- Atherosclerosis Regression from a Clinical and Anatomo-Pathological Standpoint.- Atherosclerosis in Youth.- New Lipid Lowering Agents.- LDL Apheresis.- Standardization of Apoprotein Measurement in Blood.- Cardiologists and CHD and Atherosclerosis Prevention Versus Therapy.- Rationale for Prevention in High Risk Subjects.- Hyperlipoproteinemia Therapy: When to Opt for Drug Combinations.- Hypertension as a Risk Factor.- Invasive Therapy of Coronary and Cerebrovascular Diseases.